Copertina

Targeting BCL11A through gene therapy in sickle cell disease: Will one size fit all or most?

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autore principale:	Abdulrahman Alsultan
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Pediatric Blood & Cancer
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population‐based study
di: Jiajing Scarlette Shi, et al.
Pubblicazione: (2024)

Quantifying dilated perivascular spaces in children with sickle cell disease
di: Kristine A. Karkoska, et al.
Pubblicazione: (2024)

Pain screening in youth with sickle cell disease: A quality improvement study
di: Dennis C. Vroom, et al.
Pubblicazione: (2024)

Experiences and outcomes of fertility testing in male adolescents with sickle cell disease
di: Susan Creary, et al.
Pubblicazione: (2024)

Electrocardiographic abnormalities in patients with sickle cell disease: A systematic review and meta‐analysis
di: Erfan Taherifard, et al.
Pubblicazione: (2024)

Association of hydroxyurea adherence with transcranial Doppler screenings in children with sickle cell disease
di: La'Kita M. J. Knight, et al.
Pubblicazione: (2024)

Sexually transmitted infection testing and diagnosis in adolescents and young adults with sickle cell disease
di: Joseph Walden, et al.
Pubblicazione: (2024)

Psychiatry referral and appointment attendance in a clinic for young adults with sickle cell disease
di: Elizabeth J. Prince, et al.
Pubblicazione: (2024)

Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
di: Wei‐Zhen Tang, et al.
Pubblicazione: (2024)

Characterizing medical decision‐making in sickle cell disease during childhood: Qualitative perspectives of caregivers
di: Ariel O. Blakey, et al.
Pubblicazione: (2024)

Reply to: Comment on: Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
di: Jennifer Longoria, et al.
Pubblicazione: (2024)

Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series
di: Ajibike Lapite, et al.
Pubblicazione: (2024)

The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study
di: Kemar V. Prussien, et al.
Pubblicazione: (2024)

A severe case of delayed transfusion reaction in a patient with sickle cell disease while preparing for allogeneic stem cell transplant
di: Michelle Amit, et al.
Pubblicazione: (2024)

Promise of Composite Pain Index as a single pain outcome for sickle cell disease across the lifespan
di: Reema Kashif, et al.
Pubblicazione: (2024)

Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States
di: Fathia Oladipupo, et al.
Pubblicazione: (2024)

Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project
di: Jeffrey G. Edwards, et al.
Pubblicazione: (2024)

Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy‐based refill records
di: Arlene Smaldone, et al.
Pubblicazione: (2024)

Emergency department 30‐Day emergency department revisits among people with sickle cell disease: Variations in characteristics
di: Melinda Rushing, et al.
Pubblicazione: (2024)

Body composition analysis using dual‐energy x‐ray absorptiometry in an Egyptian pediatric sickle cell disease cohort
di: Ahmed Maher Kaddah, et al.
Pubblicazione: (2024)

“Everyone screens to some extent”: Barriers and facilitators of developmental screening among children with sickle cell disease: A mixed methods study
di: Catherine R. Hoyt, et al.
Pubblicazione: (2024)

Patterns of primary and specialty care among children with sickle cell anemia
di: Pooja N. Patel, et al.
Pubblicazione: (2024)

“I was very scared when I found out my son had sickle cell”: Caregiver knowledge and attitudes toward early intervention for young children with sickle cell disease: Implications for policy and practice from a multi‐site study
di: Catherine R. Hoyt, et al.
Pubblicazione: (2024)

The relationship between cumulative risk and health‐related quality of life in youth with sickle cell disease: Moderating effects of secondary control engagement coping
di: Elise M. Belkin, et al.
Pubblicazione: (2024)

Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity
di: Mona Hamdy, et al.
Pubblicazione: (2024)

SNAP: Supportive non‐invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team
di: Robyn T. Cohen, et al.
Pubblicazione: (2024)

Informing parents of newborns with sickle cell trait detected at neonatal screening: A northern France experience
di: Malo Freppel, et al.
Pubblicazione: (2024)

Description of a national, multi‐center registry of patients with sickle cell disease and SARS‐CoV‐2 infection: Data from the Pediatric COVID‐19 United States Registry
di: Aleksandra S. Dain, et al.
Pubblicazione: (2024)

Comment on: “Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease”: Participant evaluation
di: Mary F. Martin, et al.
Pubblicazione: (2024)

Early diagnosis of sickle cell retinopathy by using ocular coherence tomography in pediatric population (7–18 years) in central India
di: Pooja Soni, et al.
Pubblicazione: (2024)

Crizotinib therapy for congenital embryonal rhabdomyosarcoma associated with an ATIC–ALK gene fusion
di: Yusuke Akane, et al.
Pubblicazione: (2024)

Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR‐T cell therapy in KMT2A‐rearranged, therapy‐related acute lymphoblastic leukemia
di: Sanila Sarkar, et al.
Pubblicazione: (2024)

Diagnostic pitfalls in assessment of ferritin following CAR‐T‐cell therapy: Understanding the hook effect
di: Roa Harb, et al.
Pubblicazione: (2024)

Hematopoietic stem cell transplantation in two sisters with bone marrow failure associated with POLE gene variants
di: Kentaro Fujimori, et al.
Pubblicazione: (2024)

BRAF‐V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first‐line therapy
di: Chan‐Juan Wang, et al.
Pubblicazione: (2024)

Early defibrotide therapy and risk factors for post‐transplant veno‐occlusive disease/sinusoidal obstruction syndrome in childhood
di: Hironori Goto, et al.
Pubblicazione: (2024)

Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics
di: Angela Steineck, et al.
Pubblicazione: (2024)

Application of cell‐free DNA fungal polymerase chain reaction for invasive fungal disease evaluation in pediatric oncology and stem cell transplant patients
di: Lauren E. Kushner, et al.
Pubblicazione: (2024)

A diagnosis of Noonan syndrome through routine whole genome sequencing in a child with an intracranial nongerminomatous germ cell tumor
di: Shathar Mahmood, et al.
Pubblicazione: (2024)

Systemic EBV‐positive T‐cell lymphoma of childhood with unusual cytogenetic findings and family history of Still's disease‐associated recurrent macrophage activation syndrome
di: Adam Jimenez, et al.
Pubblicazione: (2024)